Unmasking gastric carcinoma: Unveiling diagnostic biomarkers and the role of critical care

Abstract

We discuss the findings of Wu et al on the utility of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammatory index as diagnostic markers for gastric carcinoma (GC). We commend the study's contributions to the field and suggest a prospective study to validate these markers' sensitivity and specificity for early GC detection. We also propose developing surveillance protocols that incorporate these markers with other diagnostic methods to enhance clinical decision-making. Furthermore, we highlight the need for a more diverse patient cohort to assess the generalizability of these markers across different ethnic groups and demographic factors. Our suggestions aim to refine the application of these markers in clinical practice and to understand their potential in diverse clinical scenarios.

Keywords: Gastric carcinoma; Neutrophil-to-lymphocyte ratio; Platelet-to-lymphocyte ratio; Systemic immune-inflammatory index; Critical care

Core Tip: This commentary highlights the potential of using neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammatory index as cost-effective early diagnostic markers for gastric carcinoma, emphasizing their significance in critical care and the need for further research to incorporate these markers into a multi-modal diagnostic approach for improved patient outcomes.